Japan, March 25 -- AMGEN has got intellectual property rights for 'TRANSTHYRETIN IMMUNOGLOBULIN FUSIONS.' Other related details are as follows:
Application Number: JP,2023-179333
Category (FI): A61K39/395@N,A61P35/00,C07K14/47,C07K16/18,C07K16/28,C07K19/00,C12N15/12,C12N15/13,C12N15/62@Z,C12N15/63@Z,C12N5/10,C12P21/08
Stage: Grant (IP right document published.)
Filing Date: Oct. 18, 2023
Publication Date: Jan. 30, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....